butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Coadministration of CYP3A4 inducers may possibly minimize sufentanil amounts and efficacy, probably precipitating withdrawal syndrome in clients who have produced Actual physical dependence to sufentanil. Discon